Lupin falls over 4% in two sessions on Suprax generic concernsShares of Lupin have extended losses for second straight session after the USFDA allowed Aurobindo Pharma to sell a generic antibiotic drug...
17 Apr, 2015, 09.20 AM IST
Aurobindo Pharma gets USFDA nod to sell antibiotic oral suspensionThe approval by the USFDA is for strengths of 100 mg/5 ml and 200 mg/5 ml and the product is ready for launch, Aurobindo Pharma said in a s...
15 Apr, 2015, 01.44 PM IST
Lupin recalls two lots of antibiotic drug 'Suprax' in US marketLupin is voluntarily recalling 9,210 bottles of its antibiotic drug Suprax, used to treat bacterial infections, in the US market, according...
14 Apr, 2014, 05.02 PM IST
Have about 200 drug filings in US, 100 have got approvals: Ramesh Swaminathan, Lupin'We do expect nicotinic acid and Aspen to be launched by the end of this quarter,' says Ramesh Swaminathan.
03 Mar, 2014, 03.35 PM IST
Lupin's earnings outperform Street expectations, to stay our top pick: Kirit Gogri, Quant Broking"The US business has been a big game changer for Lupin and I am presuming that the US business would have delivered much superior numbers t...
03 Feb, 2014, 03.15 PM IST
Lupin inks licensing pact with US firm Romark Laboratories for diarrhoea drugLupin has inked a licensing pact with US-based pharma firm Romark Laboratories to market the latter's diarrhoea treatment drug 'Alinia'.
07 Aug, 2013, 02.47 PM IST
Lupin voluntarily recalls anti-infectious drug from US marketLupin is voluntarily recalling some lots of Suprax, which is used to treat common infections, from the US market on account of discolourati...
26 Apr, 2013, 04.16 PM IST
Will be interested in buying brands in US: S Ramesh, Lupin"Our current cash holdings are close to about $100-120 million and if you look at our debt-equity ratio, it is currently about 0.2. "
18 Mar, 2013, 01.53 PM IST
Lupin receives USFDA nod for Suprax oral suspensionDrug firm Lupin receives approval from the US health regulator for its Suprax oral suspension used for treating bacterial infections.
22 Feb, 2013, 03.53 PM IST
- Barclays 'Overweight' on Lupin
Barclays has retained its 'Overweight' rating on Lupin after the US FDA approved capsules for Lupin's flagship generic drug Suprax.
07 Jun, 2012, 04.10 AM IST
- Lupin receives USFDA approval for antibiotic capsules
Lupin has received approval from the US health regulator to market its generic Suprax capsules, used for treating bacterial infections.
05 Jun, 2012, 05.18 PM IST
- US market grew 16%, India grew by 21%, Japan grew by 14%: Nilesh Gupta, Lupin
In an interview with ET Now, Nilesh Gupta , Group President & Executive Director to the Board, Lupin Ltd, talks about the company's Q2 resu...
10 Nov, 2011, 04.28 PM IST
- Citi maintains 'buy' on Lupin
Citi has maintained its 'buy' rating on mid-sized Indian pharma firm Lupin, and raised its target price to Rs 1,415, following the acquisit...
03 Oct, 2009, 03.30 AM IST
- LUPIN04 Nov, 2008, 05.38 AM IST
- Analysts'Picks: Lupin
Lupin has entered into multiyear agreement with Forest to promote the latter’s VHC product AeroChamber Plus to paediatricians.
25 Aug, 2008, 06.08 AM IST
- Lupin enters into promotion pact with Ascend
Pharmaceutical firm Lupin today said it has entered into a promotion agreement with Ascend Therapeutics Inc to promote its Suprax 400mg tab...
23 Jun, 2008, 07.55 PM IST
- Lupin set to widen its base in paediatric mkt
Pharmaceutical firm Lupin on Thursday said it has received US Food and Drug Administration (USFDA) approval for Suprax Cefixime, an antibio...
12 Apr, 2007, 12.00 PM IST